To learn the fundamentals of preparing a clinical trial budget:



Similar documents
NEGOTIATING CLINICAL TRIAL BUDGETS. Debbie Williams R.N., C.C.R.C., C.R.A., A.B.N.

Case 2:10-md CJB-SS Document Filed 05/03/12 Page 1 of 5 EXHIBIT 12

LABORATORY and PATHOLOGY SERVICES

MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code

Clinical Trials Budgeting and Billing

How to Develop a Clinical Study Site Budget

Kaiser Permanente 2016 Sample Fee List *

All Acute Care Hospitals and End-Stage Renal Disease Clinics. Subject: Billing and Claim Completion Guidelines for Renal Dialysis Services

Clinical Laboratory Parameters for Crl:CD(SD) Rats. March, Information Prepared by Mary L.A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D.

December 13, 2011 Maureen Coyne

And Now, Presenting...

The Importance of Following the PROTOCOL in Clinical Trials

Kaiser Permanente 2016 Sample Fees List 1

Coding and Payment Guide for Laboratory Services. An essential coding, billing, and payment resource for laboratory and pathology services

Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA Phone:

Data Management in Clinical Trials

The Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis

CLINICAL TRIAL FEASIBILITY AND CAPACITY PLANNING FORM

Quality Monitoring Checklist

Guidance for Industry

Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR:

Determining Donor Eligibility Blood Donor vs. Stem Cell Donor. Wanda Koetz, RN, HPC Clinical Nurse Lead, Memorial Blood Centers ASFA - May 7, 2015

ADJUVANT TREATMENT CLINICAL EVALUATION NEOADJUVANT TREATMENT

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis

Cheryl K. Bernstein RN, BSN, CCRC Director Bernstein Clinical Research Center, LLC Cincinnati, Ohio

Kaiser Permanente 2015 Sample Fee List 1 Members in any deductible plan can use this list to help estimate their charges.

Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure

Section 6 Visit Checklists

Application for Research

PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8

The Medical Laboratory Licensing Regulations, 1995

A guide for the patient

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

Fundamentals of Clinical Trial Financial Management

Laboratory Services Policy

MULTIPLE MYELOMA Review & Update for Primary Care. Dr. Joseph Mignone 21st Century Oncology

CLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS

MHDO CompareMaine Updated: 9/17/2015

Simplifying Clinical Trial Eligibility Criteria

Children s Research Management System (CRMS) Version 3.0. Children s Hospital Colorado Research Institute Training Guide April 2015

Section. 37Renal Dialysis Facility

SOP for Screening of Adult Chemotherapy Electronic Prescriptions

INTERIM SITE MONITORING PROCEDURE

No Page 1 of 5. Issue Date 4/21/2014

Summary & Conclusion

Research Administration. Clinical Trial Administration Part I: Overview of Clinical Trial Management. (Presented November 12 th and 14 th 2013)

Comprehensive Study Documents List (Biomedical Studies)

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health

To Certify or Not to Certify

To Certify or Not to Certify Sandra Halvorson, BA, CCRP

ICH CRA Certification Guide March 2009

Principle Investigator Training

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)

Subpart H--Participation in Proficiency Testing for Laboratories Performing Nonwaived Testing

Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS

The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial

Why is a Comprehensive Metabolic Blood Chemistry panel included in the FNHP?

FULL LABORATORY to HOT LABORATORY DR. DAVID OLEESKY

CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]

Template for essential information to be provided for proposals including clinical trials / studies / investigations

MEDICAL ASSISTANCE BULLETIN

Pointe Scientific, Inc. Instrument Application

Version history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy

Provision of Intravenous EDTA Chelation as a Complementary and Alternative Medicine

Virginia. A guide for individuals and families. The health insurance benefits you want, at a cost you can afford

Information Pathway. Myeloma tests and investigations. Paraprotein measurement

LUNG CANCER CLINICAL TRIALS

Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems

BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT )

NCT sanofi-aventis HOE901_3507. insulin glargine

CTSC Clinical Laboratory. Clinical Laboratory Services CTSC. Clinical & Translational Science Center

The Study Site Master File and Essential Documents

Implementation Guide

How To Write A Binder Tab

Principal Investigator and Sub Investigator Responsibilities

STANDARD OPERATING PROCEDURE FORMAL COVERAGE ANALYSIS

Data Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research.

If you are signing for a minor child, you refers to your child throughout the consent document.

Core Training Outline

Clinical Trials (Post Award and CRMS) Dorothy Damron, Oncology Research Manager and CRMS Lead Scott Streibich, Clinical Research Revenue Cycle

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD

EXECUTIVE BLOOD WORK PANEL

Clinical Investigator Inspections and FDA-483 Observations

Summary of Benefits. VidantHealth.com VIDANT HOME HEALTH & HOSPICE VIDANT WELLNESS

Orientation Manual for Clinical Research Coordinators

ROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices

HOVON Staging and Response Criteria for Non-Hodgkin s Lymphomas Page 1

Including changes in health status since last exam. Known occupational exposures.

Operational aspects of a clinical trial

Intake / Admissions Processes

What is Clinical Data Management

The Ontario Cancer Research Ethics Board Overview

Routine Investigations for Liver Disease a guide

LI, Huafang MD., Ph.D. Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, Shanghai, China

Annex A. Levels 1 5 of the Clinical Research Coordinator Track in the Clinical Research WSQ Framework

RECRUITMENT STRATEGIES: WAYS TO FACILITATE RESEARCH

STUDY PROGRESS AND SAFETY MONITORING PLAN TEMPLATE

Participant & Clinical Interactions (PCI) Nursing/Coordinator Services

Transcription:

Learning Objectives: To learn the fundamentals of preparing a clinical trial budget: Identifying Potential Members of a Budgeting Team Identifying reasonable / hidden costs in budgeting Understanding the value of a feasibility review

Clinical Trial Team One of the most integrated groups How do you surround yourself? Principal Investigator Clinical Study Nurse / Trial Coordinator Sponsor / CRO (though maybe at a longer arm length!)

Extensions of Clinical Trial Team Billing Calendar Review Office Human Subjects Protection Office Contract Negotiation Group / Sponsored Programs Office Ancillary Review Committees

Determine Recruitment Potential Define reasonable & realistic accrual goals What measures are necessary to reach the desired subject population? How many subjects must be screened to identify an eligible participant? What is the recruitment time frame? What is my patient population?

DISCLAIMER!!! We will talk through many types of charges We will offer many ways of looking at things BUT, this is not the exhaustive list! Many items are protocol/institution specific

Clinical Budget Full Budget Concepts: Needs to be somewhat flexible If not in budget, sponsor is not obligated to pay Must cover all costs

Categorize Budget Items Fixed and Up- Front Costs Are needed for study conduct and incurred whether or not a subject is enrolled. Costs Related to Subject Visits Sponsor proposals usually link all budget items directly to patient visits.

Identify Universal Costs for Study Conduct What institutional approvals are needed? Are mandated fees charged? Determine institutional Indirect Cost rate

Indirect Cost Recovery (aka Facility & Administrative charges or Overhead) These are a real cost to the institution Determine correct rate to use on your study Call your institutional resource!

Budgeting a Clinical Trial Clinical Trial experience is helpful when creating and negotiating budgets Understand the nuances of treatments Things are not black and white There is a patient at the other end of the trial The care always has to come first over the protocol

Dissecting the Protocol Study Calendar Identify items that will generate expenses for the site Number and complexity of subject visits

Dissecting the Protocol Study Calendar Procedure Eligibility criteria/signed informed consent Demographic data/tumor characteristics Pre-Study X Treatment Day 15 Day 1 Day 8 Procedure Pre-Study Run-in Treatment Cycle Off treatment visit Day 1 Day 8 XDay End of cycle /Day 15 28* Eligibility criteria/signed informed consent X Demographic Tumor data/tumor characteristics history surgery, Xradiotherapy, X Tumor history surgery, radiotherapy, systemic X therapies systemic therapies Medical history X X Baseline conditions Medical history X X Physical exam X X X Non drug therapies for tumor X If appropriate Other diagnostic Baseline procedures conditions If Xappropriate Vital signs (BP, pulse) X X X ECG and chest Physical X-ray (if not already exam performed to X Only if Xclinically indicated X X follow tumor. Thoracic computed tomography (CT) scan may substitute chest X-ray ) ECOG PS X X X Hematology X X X X * X Other diagnostic procedures Blood chemistry X X X X * X Urinalysis X Only if clinically indicated X Urine pregnancy Vital test signs (BP, pulse) X X X Concomitant pharmacological treatments X X Periodically throughout study X ECG and chest X-ray (if not already X Transfusion If appropriate AE monitoring X X Periodically throughout study X performed to follow tumor. ) Disease status (up to progressive disease [PD]) X X X Reparixin administration X Days 1-21 ECOG PS X X Taxol administration X X Plasma PK sampling X Day 1,2 Blood PK sampling in case of toxicity Only if clinically indicated Optional tumor core biopsy or FNA X Non drug therapies for tumor X If approp If approp Only if clinicall Hematology X X X X Blood chemistry X X X X

Dissecting the Protocol Study Calendar Identify items that will generate expenses for the site Number and complexity of subject visits Laboratory Assessments (Examinations)

Dissecting the Protocol Laboratory Assessments 8.2 Clinical Laboratory Assessments 8.2.1 Hematology A complete blood count (CBC) with differential and platelet count will be obtained at each protocol-specified visit. 8.2.2 Serum Chemistry Serum chemistries, including albumin, alkaline phosphatase, total bilirubin, CO2, blood urea nitrogen (BUN), calcium, chloride, creatinine, glucose, lactic dehydrogenase (LDH), magnesium, phosphorus, potassium, total protein, AST (SGOT), ALT (SGPT), and sodium, will be obtained at each protocol-specified visit. 8.2.3 Urinalysis Urinalysis (with microscopic analysis) will be obtained during screening, at study Days 28 and 56, every 28 days thereafter, and at the time of treatment termination.

Dissecting the Protocol Study Calendar Identify items that will generate expenses for the site Number and complexity of subject visits Laboratory Assessments (Examinations) Study Design Study duration Accrual goal Number of participating sites Cycle length and/or limit

Billing Calendar Form to take on visit to PI to identify standard of care v. chargeable items

Billing Calendars Produce list of study procedures / calendar Principal Investigator designates Standard of Care items versus research related items Billing Calendar becomes the foundation of your budget

Preparing the Budget

Effort Estimate Team Leads estimate effort put forth by the study team Estimate time needed for study visits Staffing needs for duration of study Difficulty of meeting eligibility criteria Additional recruitment effort

Effort Estimate Effort Estimate Sheet for: Principal Investigator Additional faculty / clinician participation Data Manager/Coordinator Regulatory Manager/Coordinator Research/Treatment Nurse Medical Assistant Multi-site Study Coordination Consider support for: Finance/Accounting IT Support for Clinical Research

Effort Estimate Study Budget: 2011.041 Accrual Goal: 25 PI: Mickey Mouse Investigators: Phase 1 Participants: Multisite Trial: Yes Sponsor: Disney Study Length: 2 Data Manager: Donald Duck Accrual Length: 1.5 Screening/Enrollment Per Patient Total Accrual FTE % Visits per Patient 1 Hours per Visit Enter the value of 1x(b+c) x Accrual Goal in D11 4 Hours per patient (forms completion) 6 Total for all patients 250 0.12 Active Treatment #1 - Per Patient Total Accrual FTE % Visits per Patient 9 Hours per Visit Enter the value of ax(b+c) x Accrual Goal in D16 1.5 Hours per patient (forms completion) 2 Total for all patients 787.5 0.38 Follow-up - Per Patient Total Accrual FTE % Visits per Patient 1 Hours per Visit Enter the value of a(b+c) x Accrual Goal in D26 1 Hours per patient (forms completion) 1 Total for all patients 75 0,03 Monitor Visits-Meetings Total number of visits 36 Hours monitor is on site Enter the value of (a x b x c%)+d in D32 16 % of Data Mgr Time w/ Monitor 50% Queries 30 Total monitor 318 318 Support Svcs. DM Orientation to include protocol review, start-up, etc. (hrs.) 8-16 hours 16 F2F Meetings w/sponsor (hrs.) 0 Phone w/sponsor (hrs) Telecons etc. 24 F2F w/pi (hrs) 1 hr/month x study length 39 DSMC (hrs) 0 CTO Dbase Requirements (hrs) Velos if Sponsor 220 PSV (hrs) Pre-site (8 hrs) 8 IV (hrs) SIV (8hrs) 10 CV (hrs) Close-out (8-16 hrs) 8 Total Support Svcs. Sum of a through i 325 325 TOTALS 2331 56% Survival? Estimated pt survival x the number of visits

Budget Full Title: A Phase I Study to Teach New Staff About Billing Calendars and Budgets Study Sponsor: Principal Investigator: Disney Mickey Mouse Budget Prepared by: Preparer's Phone #: Minnie Mouse Estimated # of Subjects: 555.0749 Version Date: Ame 1, 30 JAN 2011 20 Screen Cycle 1 28 Day Cycle Cycle 2 28 Day Cycle Cycle 3 28 Day Cycle Cost Day -14 to -1 Day 1 Day 8 Day 15 Day 22 Day 1 Day 8 Day 15 Day 22 Day 1 Day 8 Day 15 Day 22 OFFICE VISITS Physical Examination $145.00 RC RC RC RC LABS Hematology - CBCPD $75.00 RC RC $75.00 RC $75.00 RC RC RC RC Serum Chemistry - COMP $75.00 RC RC RC RC RC RC RC Direct Bilirubin $30.00 $30.00 $30.00 $30.00 $30.00 $30.00 $30.00 $30.00 Uric Acid $45.00 $45.00 $45.00 $45.00 $45.00 $45.00 $45.00 $45.00 LDH $50.00 $50.00 $50.00 $50.00 $50.00 $50.00 $50.00 $50.00 Serum Pregnancy Test $50.00 INVOICE INVOICE INVOICE INVOICE Urinalysis - Macro $25.00 RC $25.00 RC RC Urinalysis - Micro $25.00 $25.00 $25.00 $25.00 $25.00 PROCEDURES CT Scan - Abdomen $1,500.0 0 RC RC CT Scan - Chest $1,500.0 0 RC RC CT Scan - Pelvis $1,500.0 0 RC RC Bone Marrow Aspirate $500.00 RC INVOICE $500.00 RC Bone Marrow Biopsy $1,000.0 0 RC INVOICE $1,000.00 RC ECG (12 Lead) $100.00 $300.00 $600.00 $600.00 $600.00 $600.00 $300.00 $300.00 $300.00 $300.00 $300.00 $300.00 MEDICATIONS DSY-1203 Prep $50.00 $50.00 $50.00 $50.00 $50.00 $50.00 $50.00 $50.00 $50.00 $50.00 $50.00 $50.00 $50.00 DSY-1203 Infusion $475.00 $475.00 $475.00 $475.00 $475.00 $475.00 $475.00 $475.00 $475.00 $475.00 $475.00 $475.00 $475.00 PERSONNEL Principal Investigator $150.00 $150.00 $150.00 $150.00 $150.00 $150.00 $150.00 $150.00 $150.00 $150.00 $150.00 $150.00 $150.00 $150.00 Research Nurse $375.00 $568.00 $568.00 $350.00 $568.00 $350.00 $375.00 $375.00 $375.00 $375.00 $375.00 $375.00 $375.00 $375.00 Medical Assistant $75.00 $141.50 $141.50 $75.00 $75.00 $75.00 $75.00 $75.00 $75.00 $75.00 $75.00 $75.00 $75.00 $75.00 Data Manager $250.00 $250.00 $250.00 $250.00 $250.00 $250.00 $250.00 $250.00 $250.00 $250.00 $250.00 $250.00 $250.00 $250.00 Regulatory Associate $100.00 $100.00 $100.00 $100.00 $100.00 $100.00 $100.00 $100.00 $100.00 $100.00 $100.00 $100.00 $100.00 $100.00

Visit Total $1,659 $2,509 $2,125 $2,393 $2,125 $3,425 $1,775 $1,900 $1,775 $1,625 $1,775 $1,600 $1,775 Overhead $414 $627 $531 $598 $531 $856 $443 $475 $443 $406 $443 $400 $443 TOTAL $2,074 $3,136 $2,656 $2,991 $2,656 $4,281 $2,218 $2,375 $2,218 $2,031 $2,218 $2,000 $2,218 INVOICABLES (Including Overhead) Study Activation Ravitz Phase I Unit Setup Fee IRBMED Submission $2,000 1 $2,000 Budget Screen, Cycle 1 Cycle 2 Cycle 3 GRAND TOTAL Per patient total $10,812 Per patient total $8,875 Per patient total $6,775 $6,400 1 $6,400 Overhead $2,703 Overhea $2,218 Overhea $1,693 $1,800 1 $1,800 TOTAL $13,515 TOTAL $11,09 3 Per patient total Overhea d $26,462 $6,615 TOTAL $8,468 TOTAL $33,077 IDS Setup Service IRB Annual Review Amendments External IND/AE/SAE processing for IRB Investigational Drug Service Maintenance per month Overtime Patient Travel Urinalysis - Micro $1,437 1 $1,437 $500 1 $500 $500 4 $2,000 $25 100 $2,500 $62 24 $1,500 $65 10 $650 $180 5 $900 $25 4 $100 TOTAL $19,787 Start up Total: $11,637

Consider Hidden Study Costs Delayed start Informed consent process Increased salaries & operating costs over time Travel to clinics or offsite locations Hotel Stays Tolls / Mileage Meals

More Hidden Study Costs Unscheduled visits Overhead costs for a la carte or one-time procedures Tracking study funds Audits

Consider Closing Costs Don t forget Closing costs occur AFTER subjects complete study and BEFORE contract ends Query resolution to close database Sponsor s close-out visit Pharmacy close-out IRB termination Long-term storage of research records

Potentially Unallowable Costs: Finder s fees/referral fees Enrollment incentives Paperwork completion incentives

Budget Internal Documentation/budgets should match Create detailed budget by visit By cycle In sponsor required format

Feasibility Comparison The comparison of what you truly need to what you can negotiate. How do you identify the institutional investment in a project? Always compare any sponsor offered amounts with information you have When do you say (for financial reasons) you can t do a study?

Negotiation Areas of resistance: Study team salaries Start up fees Expensive procedures Procedures should be standard of care

Negotiation Tips to overcome resistance: Justification outline of start up fees Increase cost of one item to reduce the cost of another Additional invoicable items Ask for more than you need, so you can reduce costs and satisfy sponsor later Clarify procedure requirements to see if a less expensive option can be used PI interview to determine care designations *Remember, the sponsor WANTS to work with you!

Bringing the Team back together Final Logistics Meeting Identifying equipment/medications/supplies provided by sponsor (Kits for labs, PK draws, etc.) Verifying number of patients expected to accrue Fielding questions/feedback from study team that need to go to sponsor in financial areas Logistics for conducting trial

Words to the Wise: Continually Revisit the Costs Even if you are mid-study! Increased mid-study workload may justify additional sponsor funding If sponsor extends the study period, consider whether that promotes more costs Data capture may cost more